Drug Shortage Report for AURO-PERINDOPRIL

Last updated on 2024-10-25 History
Report ID 204530
Drug Identification Number 02459817
Brand name AURO-PERINDOPRIL
Common or Proper name AURO-PERINDOPRIL
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) PERINDOPRIL ERBUMINE
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 3x10 Blst
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-09-15
Actual start date 2023-11-15
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-10-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v36 2024-10-25 French Compare
v35 2024-10-25 English Compare
v34 2024-10-25 English Compare
v33 2024-09-27 French Compare
v32 2024-09-27 English Compare
v31 2024-08-27 French Compare
v30 2024-08-27 English Compare
v29 2024-07-29 French Compare
v28 2024-07-29 English Compare
v27 2024-06-13 French Compare
v26 2024-06-13 English Compare
v25 2024-05-24 English Compare
v24 2024-04-18 French Compare
v23 2024-04-18 English Compare
v22 2024-03-27 French Compare
v21 2024-03-27 English Compare
v20 2024-02-27 French Compare
v19 2024-02-27 English Compare
v18 2024-02-12 French Compare
v17 2024-02-12 English Compare

Showing 1 to 20 of 36